Clinical Trial Update: Bevacizumab Versus Ranibizumab for the Treatment of Diabetic Macular Edema [Phase 2]

View source ↗

Summary

Phase 2 clinical trial comparing bevacizumab and ranibizumab for diabetic macular edema; status is not specified.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema
• Diabetic Retinopathy

Drugs mentioned

• Avastin (bevacizumab)
• Lucentis (ranibizumab)

Snippet

Sponsor: University of Sao Paulo | Conditions: Diabetic Retinopathy, Macular Edema | Phase 2 | Status: UNKNOWN